According to the Chinese Chamber of Commerce, the export of Chinese pharmaceuticals to emerging markets such as Australasia, ASEAN, Russia and other countries grew as much as 20 % last year. The number of EU CEP-certified products rose by 56 % in 2013, reacing a total number of 428, and US-approved DMP files reached 1116.

China Bio news release, May 5, 2014